Back to search

Cs Pharmaceuticals Limited

13027523

active
Private Limited Company
england wales
Companies House
Health Score
90 / 100

Healthy

30/30
Filing
20/30
Financial
40/40
Risk

No risk factors detected.

Details

167-169 5TH FLOOR, LONDON, W1W 5PF
Incorporated 18/11/2020

Compliance

Last accounts

31/12/2024

micro entity

Next accounts due

30/09/2026

On track

Confirmation statement

Last: 02/10/2025

Due 16/10/2026

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Mr Steven Charles Andrew Harris

director · Since 18/11/2020

CHAIRMAN

BRITISH · ENGLAND · Age 60

Also on 7 other boards

Mr Darren Mercer

director · Since 01/06/2021

CHIEF EXECUTIVE

BRITISH · ENGLAND · Age 44

Professor Andrew Frederick Wilks

director · Since 22/06/2021

BIOTECH ENTREPRENEUR

BRITISH · AUSTRALIA · Age 70

Also on 1 other board

Mr David Ian Wilson

director · Since 29/07/2021

INVESTMENT BANKER

BRITISH · ENGLAND · Age 63

Also on 9 other boards

Mr Roberto Lee

director · Since 01/12/2021

COMPANY DIRECTOR

CHINESE · CHINA · Age 52

Mr John Dawson

director · Since 01/06/2022

COMPANY DIRECTOR

BRITISH · UNITED KINGDOM · Age 66

Professor Bruce Robinson

director · Since 23/10/2024

DOCTOR

AUSTRALIAN · AUSTRALIA · Age 69

Persons with Significant Control

Mr Steven Charles Andrew Harris

75–100% shares
75–100% votes
Appoint directors

British · England · Age 60

167-169, 5th Floor, London, W1W 5PF

Notified 18/11/2020

CompanyRankvs 302+ SIC 72110 peers
78

Financial strength95th percentile among SIC peers · 24/25
Employees87th percentile among SIC peers · 13/15
LiquidityCurrent ratio 2.72× · 20/20
Longevity6 years trading (max 15) · 6/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength24/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees13/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity20/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity6/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2024

Net Worth

£2.4M

Balance sheet strength

Cash

Cash in the bank

Net Current Assets

£443k

Working capital

Current Assets

£701k

Current Liabilities

£258k

Fixed Assets

£2.6M

6avg. employees

Balance Sheet

Assets less current liabilities£3.0M
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20242.72-£798k
20232.83-£807k
20226.38+£1.1M
202117.77

Derived from filed accounts. Not audited figures.